Skip to main content

Table 1 Characteristics of the study patients, median (range) or n (%)

From: Hazards to avoid in future neonatal studies of nasal high-frequency oscillatory ventilation: lessons from an early terminated trial

 

nHFOV (n = 4)

nCPAP (n = 2)

At birth

 Gestational age (weeks)

25 0/7 (23 4/7–26 3/7)

24 0/3 (23 6/7–24 6/7)

 Birth weight (g)

503 (420–568)

668 (550–786)

 Male

2 (50)

1 (50)

At study entry

 Chronological age (days)

19 (15–28)

16 (13–19)

 Actual weight (g)

667 (475–700)

800 (775–825)

 Surfactant treatment

4 (100)

2 (100)

 Pmean (cm H2O)

8.5 (8.3–9.5)

8.2 (6.4–10)

 FiO2 (%)

31 (30–38)

26.5 (25–28)

 Intraventricular haemorrhage 3°–4°

0 (0)

2 (100)